ストックスクリーナーアプリを入手
15.96
9.50%
1.385
アフターアワーズ：
15.80
-0.165
-1.03%
前日終値:
$14.58
開ける：
$14.63
24時間の取引高:
179.97K
Relative Volume:
1.94
時価総額：
$332.14M
収益：
$214.33M
当期純損益:
$-38.98M
株価収益率:
-8.4843
EPS:
-1.8817
ネットキャッシュフロー:
$6.74M
1週間 パフォーマンス:
+11.25%
1か月 パフォーマンス:
+6.29%
6か月 パフォーマンス:
+6.47%
1年 パフォーマンス:
+71.59%
1日の値動き範囲:
$14.47
$15.99
1週間の範囲:
$13.71
$15.99
52週間の値動き範囲:
$7.08
$20.90
Amarin Corp Adr Stock (AMRN) Company Profile
名前
Amarin Corp Adr
セクター
電話
353 1 6699 020
住所
SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2
Compare AMRN vs LLY, JNJ, ABBV, NVS, AZN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMRN
Amarin Corp Adr
|
15.96 | 303.32M | 214.33M | -38.98M | 6.74M | -1.8817 |
|
LLY
Lilly Eli Co
|
1,001.35 | 900.48B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.71 | 584.62B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
227.01 | 402.17B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
NVS
Novartis Ag Adr
|
161.59 | 310.63B | 54.72B | 14.02B | 15.32B | 7.1855 |
|
AZN
Astrazeneca Plc
|
194.99 | 302.33B | 58.80B | 10.24B | 8.98B | 3.2788 |
Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-20 | 再開されました | JP Morgan | Underweight |
| 2023-10-25 | ダウングレード | Jefferies | Buy → Hold |
| 2023-01-06 | アップグレード | Jefferies | Hold → Buy |
| 2022-05-06 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-05-05 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-05-05 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-05-04 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2021-05-12 | ダウングレード | Goldman | Neutral → Sell |
| 2020-09-29 | 再開されました | JP Morgan | Neutral |
| 2020-08-26 | 開始されました | Piper Sandler | Overweight |
| 2020-05-05 | 開始されました | Northland Capital | Outperform |
| 2020-03-31 | ダウングレード | Goldman | Buy → Neutral |
| 2020-03-31 | ダウングレード | Jefferies | Buy → Hold |
| 2020-03-31 | アップグレード | Oppenheimer | Underperform → Perform |
| 2020-03-13 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-02 | 開始されました | Cowen | Outperform |
| 2020-02-18 | アップグレード | Citigroup | Neutral → Buy |
| 2020-01-06 | 開始されました | JP Morgan | Neutral |
| 2019-12-16 | ダウングレード | Stifel | Buy → Hold |
| 2019-11-20 | 開始されました | Oppenheimer | Underperform |
| 2019-11-18 | ダウングレード | Citigroup | Buy → Neutral |
| 2019-11-15 | 繰り返されました | SVB Leerink | Outperform |
| 2019-10-31 | 開始されました | Aegis Capital | Buy |
| 2019-10-15 | 開始されました | Goldman | Neutral |
| 2019-08-14 | 開始されました | SVB Leerink | Outperform |
| 2019-07-09 | 繰り返されました | Jefferies | Buy |
| 2019-06-17 | 開始されました | ROTH Capital | Buy |
| 2019-03-22 | 開始されました | Stifel | Buy |
すべてを表示
Amarin Corp Adr (AMRN) 最新ニュース
Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks - The Motley Fool
AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know - Finviz
Amarin Corporation Plc Sponsored ADR Trade Ideas — SWB:EH3 - TradingView
Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss - Finviz
Amarin Corp (NASDAQ:AMRN) Narrows Losses and Beats Adjusted EPS in Q4 2025 - ChartMill
Amarin (AMRN) Trailing Losses Narrow To US$38.8 Million Challenging Bearish Narratives - Sahm
BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? - Yahoo Finance
Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights - Finviz
AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations - Finviz
China Universal Asset Management Co. Ltd. Sells 76,302 Shares of Amarin Corporation PLC $AMRN - Defense World
Net current asset value per share of Amarin Corporation Plc Sponsored ADR – MUN:EH3 - TradingView — Track All Markets
Companies Like Amarin (NASDAQ:AMRN) Are In A Position To Invest In Growth - Sahm
Tops & Flops Stocks - sharewise.com
Amarin (AMRN) Unprofitable as Losses Worsen, Profit Growth Forecasts Test Bullish Turnaround Hopes - Sahm
Leerink Partners raises Amarin stock price target to $12 on strong Q3 - Investing.com
FDA updates fenofibrate labels to reflect lack of cardiovascular benefit - Investing.com
Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program - ADVFN
Cash from operating activities of Amarin Corporation Plc Sponsored ADR – SWB:EH3 - TradingView
Amarin Corporation plc (NASDAQ:AMRN) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - Sahm
Amarin Corporation plc Announces $17.8 Million Registered Direct Offering of American Depositary Shares - ADVFN
Amarin stock rises after ESC Congress data on VASCEPA mechanism - Investing.com
Earnings call transcript: Amarin Q2 2025 sees revenue beat, stock stable - Investing.com
Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Yahoo Finance
Amarin Gears Up to Report Q2 Earnings: Here's What to Expect - Finviz
3 Strong Buy Breakout Stocks for Explosive Returns - The Globe and Mail
FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill - Finviz
PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study - Finviz
Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU - Nasdaq
Amarin stock jumps after $25 million licensing deal with Recordati - Investing.com
Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma - Finviz
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
KURA Stock Rises More Than 15% This Past Week: Here's Why - The Globe and Mail
SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease - Finviz
Kymera Stock Gains on Positive Data on Investigational Dermatitis Drug - Finviz
Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines - Finviz
Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year? - Yahoo Finance
VSTM Stock Soars 22% in a Month on Ovarian Cancer Combo Drug Approval - Finviz
Amarin Corp PLC Share Price ADR Each Rep 20 Ord Spon - Hargreaves Lansdown
Amarin announces ADS ratio change to meet Nasdaq requirements - Investing.com
Amarin adds investment expert Michael Torok to Board By Investing.com - Investing.com
Amarin urged to review strategy by major shareholders - Investing.com
The Market Doesn't Like What It Sees From Amarin Corporation plc's (NASDAQ:AMRN) Revenues Yet As Shares Tumble 26% - Sahm
Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance
Amarin Announces 1-for-20 Reverse Stock Split - TipRanks
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
China approves VASCEPA to reduce cardiovascular risk - Investing.com
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Investing.com UK
Free float of Amarin Corporation Plc Sponsored ADR – NASDAQ:AMRN - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Sarissa Capital Calls for Amarin Special Meeting to Vote on Its Nominees - 24/7 Wall St.
Earnings BeforeStock ScreenerSnapshot - Finviz
Amarin Corp Adr (AMRN) 財務データ
収益
当期純利益
現金流量
EPS
1.31%
2.66%
大文字化:
|
ボリューム (24 時間):